Stahl-Hennig Christiane, Eisenblätter Martin, Jasny Edith, Rzehak Tamara, Tenner-Racz Klara, Trumpfheller Christine, Salazar Andres M, Uberla Klaus, Nieto Karen, Kleinschmidt Jürgen, Schulte Reiner, Gissmann Lutz, Müller Martin, Sacher Anna, Racz Paul, Steinman Ralph M, Uguccioni Mariagrazia, Ignatius Ralf
Laboratory of Infection Models, German Primate Center, Göttingen, Germany.
PLoS Pathog. 2009 Apr;5(4):e1000373. doi: 10.1371/journal.ppat.1000373. Epub 2009 Apr 10.
Toll-like receptor (TLR) ligands are being considered as adjuvants for the induction of antigen-specific immune responses, as in the design of vaccines. Polyriboinosinic-polyribocytoidylic acid (poly I:C), a synthetic double-stranded RNA (dsRNA), is recognized by TLR3 and other intracellular receptors. Poly ICLC is a poly I:C analogue, which has been stabilized against the serum nucleases that are present in the plasma of primates. Poly I:C(12)U, another analogue, is less toxic but also less stable in vivo than poly I:C, and TLR3 is essential for its recognition. To study the effects of these compounds on the induction of protein-specific immune responses in an animal model relevant to humans, rhesus macaques were immunized subcutaneously (s.c.) with keyhole limpet hemocyanin (KLH) or human papillomavirus (HPV)16 capsomeres with or without dsRNA or a control adjuvant, the TLR9 ligand CpG-C. All dsRNA compounds served as adjuvants for KLH-specific cellular immune responses, with the highest proliferative responses being observed with 2 mg/animal poly ICLC (p = 0.002) or 6 mg/animal poly I:C(12)U (p = 0.001) when compared with immunization with KLH alone. Notably, poly ICLC -- but not CpG-C given at the same dose -- also helped to induce HPV16-specific Th1 immune responses while both adjuvants supported the induction of strong anti-HPV16 L1 antibody responses as determined by ELISA and neutralization assay. In contrast, control animals injected with HPV16 capsomeres alone did not develop substantial HPV16-specific immune responses. Injection of dsRNA led to increased numbers of cells producing the T cell-activating chemokines CXCL9 and CXCL10 as detected by in situ hybridization in draining lymph nodes 18 hours after injections, and to increased serum levels of CXCL10 (p = 0.01). This was paralleled by the reduced production of the homeostatic T cell-attracting chemokine CCL21. Thus, synthetic dsRNAs induce an innate chemokine response and act as adjuvants for virus-specific Th1 and humoral immune responses in nonhuman primates.
Toll样受体(TLR)配体正被视为诱导抗原特异性免疫反应的佐剂,如在疫苗设计中。聚肌苷酸-聚胞苷酸(poly I:C),一种合成双链RNA(dsRNA),可被TLR3和其他细胞内受体识别。聚肌胞苷酸(Poly ICLC)是一种poly I:C类似物,它对灵长类动物血浆中存在的血清核酸酶具有稳定性。另一种类似物聚肌苷酸胞苷酸12尿苷酸(Poly I:C(12)U)毒性较小,但在体内比poly I:C稳定性更低,且TLR3对其识别至关重要。为了在与人类相关的动物模型中研究这些化合物对诱导蛋白质特异性免疫反应的影响,将恒河猴皮下注射钥孔戚血蓝蛋白(KLH)或人乳头瘤病毒(HPV)16衣壳蛋白,同时添加或不添加dsRNA或对照佐剂TLR9配体CpG-C。所有dsRNA化合物均作为KLH特异性细胞免疫反应的佐剂,与单独用KLH免疫相比,当给予2mg/只动物的聚肌胞苷酸(p = 0.002)或6mg/只动物的聚肌苷酸胞苷酸12尿苷酸(p = 0.001)时,观察到最高的增殖反应。值得注意的是,聚肌胞苷酸——但相同剂量的CpG-C则不然——也有助于诱导HPV16特异性Th1免疫反应,而两种佐剂均支持通过ELISA和中和试验测定的强烈抗HPV16 L1抗体反应的诱导。相比之下,单独注射HPV16衣壳蛋白的对照动物未产生大量HPV16特异性免疫反应。注射dsRNA导致在注射后18小时通过引流淋巴结原位杂交检测到产生T细胞激活趋化因子CXCL9和CXCL10的细胞数量增加,以及血清CXCL10水平升高(p = 0.01)。这与稳态T细胞吸引趋化因子CCL21的产生减少相平行。因此,合成dsRNAs诱导先天性趋化因子反应,并在非人灵长类动物中作为病毒特异性Th1和体液免疫反应的佐剂。